Edwards Lifesciences Co. (NYSE: EW) had its price target lowered by analysts at Truist Financial Co. from $78.00 to $75.00. They now have a "hold" rating on the stock.
Sands Capital Select Growth Fund Sold Edwards Lifesciences Corporation (EW) For Better Opportunities [Yahoo! Finance]
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of Patients
Jim Cramer Calls Edwards Lifesciences (EW) a Hold – Prefers Boston Scientific Right Now! [Yahoo! Finance]
Peijia Medical Announces 2024 Annual Results [Yahoo! Finance]